Although many studies have identified the prognostic properties of Ki67 in early breast cancer, these studies vary substantially regarding the selection of patients, the tumor molecular subtypes included, and the oncological outcomes considered (Supplementary Figure 13, Supplementary Table 5, available online). This evidence concerns the gene MKI67 and breast carcinoma.